SBPH - Spring Bank Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
352
946
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
22,633
19,751
13,075
14,017
7,539
Selling General and Administrative
9,585
8,719
8,178
5,739
5,003
Total Operating Expenses
32,218
28,470
21,253
19,756
12,542
Operating Income or Loss
-32,218
-28,470
-21,253
-19,404
-11,596
Interest Expense
-
-
-
-
6
Total Other Income/Expenses Net
8,841
4,617
-6,795
1,942
0
Income Before Tax
-22,087
-22,854
-27,679
-17,366
-11,564
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-22,087
-22,854
-27,679
-17,366
-11,564
Net Income
-22,087
-22,854
-27,679
-17,366
-11,564
Net Income available to common shareholders
-18,250
-22,854
-27,679
-17,366
-11,564
Reported EPS
Basic
-
-1.59
-2.48
-2.39
-1.95
Diluted
-
-1.88
-2.48
-2.39
-1.95
Weighted average shares outstanding
Basic
-
14,372
11,153
7,257
5,933
Diluted
-
14,619
11,153
7,257
5,933
EBITDA
-
-28,182
-21,095
-19,286
-11,470